- Report
- August 2023
- 51 Pages
Israel
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Colombia
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Italy
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
South Korea
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
India
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
South Africa
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Spain
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 1300 Pages
Global
From €5590EUR$6,230USD£4,811GBP
€7986EUR$8,900USD£6,873GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €3078EUR$3,430USD£2,649GBP
€4397EUR$4,900USD£3,784GBP
- Report
- August 2023
- 300 Pages
Europe
From €3078EUR$3,430USD£2,649GBP
€4397EUR$4,900USD£3,784GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €3078EUR$3,430USD£2,649GBP
€4397EUR$4,900USD£3,784GBP
- Report
- August 2023
- 300 Pages
Latin America
From €3078EUR$3,430USD£2,649GBP
€4397EUR$4,900USD£3,784GBP
- Report
- December 2023
- 245 Pages
Global
€4482EUR$4,995USD£3,857GBP
- Report
- February 2024
- 177 Pages
Global
€4482EUR$4,995USD£3,857GBP
- Report
- January 2024
- 106 Pages
Global
€4482EUR$4,995USD£3,857GBP
- Report
- August 2023
- 80 Pages
Saudi Arabia
From €1346EUR$1,500USD£1,158GBP
- Report
- August 2023
- 80 Pages
India
From €1346EUR$1,500USD£1,158GBP
- Report
- August 2023
- 255 Pages
Global
From €2243EUR$2,500USD£1,931GBP
- Report
- August 2022
- 40 Pages
Saudi Arabia
From €1346EUR$1,500USD£1,158GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more